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Dear Editors:
We appreciate the opportunity to clarify the statistical
treatment of our data. During the preparation of the
manuscript, we did consider the use of the t-test as
proposed by Dr. Buyske. Indeed, the z-test requires that
the standard deviation be known, while we estimated the
standard deviation from the sample. However, the t-test is
not ideal either. A t-test compares two groups of values and
the statistics rely on the standard deviation of both groups.
It is unconventional to use the t-test to compare a single
value, i.e., that of the miRNA in each case of autism against
a group of values. By definition, the single values do not
have a standard deviation. For this reason, we chose the z-
test as a first-level less stringent screen to assess differential
expression between one autistic case and 13 normal cases
for each miRNA.
We had also addressed the issue raised by Dr. Buyske
with a nonparametric approach—the Wilcoxon rank test.
However, the statistical power of the rank order test is
rather weak and, more importantly, we lose the information
in the differences in magnitude of the miRNAs. A strength
of the method we used to profile the miRNAs—real-time
PCR—is its ability to detect a broad dynamic range of
miRNA expression. Our method was preferable to capture
this quantitative parameter. However, the miRNAs with p-
values that rank among the top using the parametric test
remain among the top with the nonparametric test.
The statistical testing as suggested by Dr. Buyske does
demonstrate some differentially expressed miRNAs. With a
one-sided t-test, our top five miRNAs remained statistically
significant. The main difference between the z-test and t-
test in a sense is the p-value cutoff. The z-test is indeed less
stringent than the t-test and the two-sided t-test further
increases the stringency. On the other hand, the Bonferroni
correction for multiple hypotheses testing, applied in the
manuscript, is often considered overly stringent. If we
control for multiple hypotheses with a 5% false discovery
rate (FDR) rather than the Bonferroni correction on t-
statistics, the number of dysregulated miRNAs goes from
five to 13. One could further argue that even the FDR is
overly stringent because many miRNAs are co-regulated,
and therefore treating each as an independent query may be
unnecessarily conservative.
Whichever the test and correction, we did provide all p-
values signifying the difference between each autistic case
and the normal cases for each miRNA, and these p-values
are not affected by the significance cutoff. These p-values
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San Francisco, CA 94143, USAallow the reader to see all the data and apply their own
cutoff as Dr. Buyske has done.
We think that our approach, z-test (less stringent than t-
test) plus Bonferroni correction (more stringent than FDR),
as well as the inclusion of all the raw data in our manuscript
provides researchers a better opportunity to explore the
effects of miRNAs on autism. Some validation of the results
appears in our paper. We reported that, among the implicated
miRNAs, severaltarget genesknowntobeinvolvedinautism
are predicted. Furthermore, four of the miRNAs we reported
(miR-23a, miR-132, miR-146b, and miR-320) were reported
inasubsequentstudyusinglymphoblastoidcelllinesfromsix
subjects with autism and six controls (Talebizadeh Z et al.,
Autism Research 1:240–250, 2008).
We thank Dr. Buyske for his comments and the
opportunity to better convey the findings.
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